| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/14/1992 | WO1992002621A3 Allergens of alder pollen and applications thereof |
| 05/14/1992 | WO1992001718A3 Functionally active selectin-derived peptides and ligand for gmp-140 |
| 05/14/1992 | CA2096016A1 Diagnostic testing for campylobacter jejuni or coli injection using antigens |
| 05/14/1992 | CA2095356A1 Pharmaceutical preparation for the treatment of prolonged coagulation time |
| 05/14/1992 | CA2095330A1 Polypeptide with kd hmfg differentiation antigen binding specificity |
| 05/14/1992 | CA2094378A1 Development of dna probes and immunological reagents of human tumor associated antigens |
| 05/13/1992 | EP0485361A1 Pre-S gene codes peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers |
| 05/13/1992 | EP0484863A1 A monoclonal antibody and a method for measuring malondialdehyde-reacted low-density-lipoproteins |
| 05/13/1992 | EP0484787A2 HCV-specific peptides, process for obtaining them and their use |
| 05/13/1992 | EP0484512A1 Human peripheral blood cells in an immunocompromised host |
| 05/13/1992 | EP0484500A1 Recombinant protein which binds to a complex viral antigen of hiv-1 |
| 05/13/1992 | EP0484452A1 Fibulin |
| 05/12/1992 | US5112954 Antibodies specific for cancer cells |
| 05/12/1992 | US5112953 Radiolabeled proteins for diagnostic or therapeutic use |
| 05/12/1992 | US5112952 Composition and method for isolation and purification of Immunoglobulin M |
| 05/12/1992 | US5112951 Separation of anti-metal chelate antibodies |
| 05/12/1992 | US5112948 Methods and compositions for inducing monocyte cytotoxicity |
| 05/12/1992 | US5112946 Polypeptides and proteins with mutant segments for treatment of cardiovascular disorders and antitumor agents |
| 05/12/1992 | US5112945 Preparation of islet amyloid polypeptides (iapp) and antibodies to iapp |
| 05/12/1992 | US5112754 Tissue plasminogen-activating factor and nonoclonal antibody |
| 05/12/1992 | US5112738 Detection of histamine release |
| 05/12/1992 | US5112737 Monoclonal antibodies against activated ras proteins with amino acid mutations at position 13 of the protein |
| 05/12/1992 | US5112606 Method of producing antibodies using colloidal metal as carrier |
| 05/10/1992 | WO1992008804A1 Erythrocytes and thrombo-erythrocytes as target specific agents |
| 05/10/1992 | WO1992008495A1 Cytokine immunoconjugates |
| 05/10/1992 | CA2095925A1 Erythrocytes and thrombo-erythrocytes as target specific abents |
| 05/10/1992 | CA2055177A1 Porcine seroconversion panels |
| 05/07/1992 | WO1992007579A1 Soluble mannose receptor peptides |
| 05/07/1992 | DE4034982A1 New peptide(s) corresponding to part of HCV C-100-3 construct - useful in vaccines and in binding assays, e.g. to distinguish between acute and chronic infection |
| 05/07/1992 | CA2095729A1 Soluble mannose receptor peptides |
| 05/06/1992 | WO1992007879A1 Biological active material covalently immobilized on to azlactone-functional polymeric supports and method for preparing it |
| 05/06/1992 | EP0484148A1 A method for producing a new medicine for both treating and preventing peptic ulcer diseases and gastritis and thus formulated medicines |
| 05/06/1992 | EP0483961A1 Specific binding agents |
| 05/06/1992 | EP0483911A2 Chicken anemia virus vaccine and diagnostic reagent |
| 05/06/1992 | EP0483281A1 Recombinant human thyroid peroxidase |
| 05/06/1992 | EP0483247A1 Recombinantly produced human membrane cofactor protein (mcp) |
| 05/06/1992 | EP0483143A1 Membrane affinity apparatus and purification methods related thereto. |
| 05/06/1992 | EP0461180A4 Development of a monoclonal antibody based detection system for listeria monocytogenes |
| 05/06/1992 | CA2093641A1 Biologically active material covalently immobilized with high bound specific biological activity and method of preparing same |
| 05/05/1992 | US5110913 Ion exchanging with sulfopropyl agarose, washing at slightly higher pH, elution at still higher pH |
| 05/05/1992 | US5110910 Deactivation of viruses in antibody source followed by precipitation of antibodies |
| 05/05/1992 | US5110908 Haemophilus influenzae peptides and proteins |
| 05/05/1992 | US5110906 Derivatives of soluble T-4 |
| 05/05/1992 | US5110833 Preparation of synthetic enzymes and synthetic antibodies and use of the thus prepared enzymes and antibodies |
| 05/05/1992 | US5110795 Methods and compositions for the treatment of inflammatory bowel diseases and conditions |
| 05/05/1992 | US5110738 Genetic engineering; hybridomas of melanoma and spleen cells |
| 05/05/1992 | US5110730 Human tissue factor related DNA segments |
| 05/02/1992 | CA2054830A1 Method for producing a new medicine for both treating and preventing peptic ulcer diseases and gastritis, and it's formulated medicines |
| 05/01/1992 | WO1992008731A2 T-cadherin adhesion molecule |
| 05/01/1992 | WO1992007952A1 Peptide binding assays with mhc antigens |
| 05/01/1992 | CA2095323A1 Peptide binding assays with mhc antigens |
| 05/01/1992 | CA2095115A1 T-cadherin adhesion molecule |
| 05/01/1992 | CA2054542A1 Chicken anemia virus vaccine and diagnostic |
| 04/30/1992 | WO1992007254A2 Use of disulphide bidged substances |
| 04/30/1992 | WO1992007084A1 Purified cdw52-specific antibodies |
| 04/30/1992 | WO1992007083A1 Antibodies against the urokinase receptor and their use |
| 04/30/1992 | WO1992007077A1 Engineered bacteriophages and vaccines containing them |
| 04/30/1992 | WO1992007075A1 Preparation of chimaeric antibodies using the recombinant pcr strategy |
| 04/30/1992 | WO1992007074A1 Polypeptide of a growth factor receptor family, application in the diagnosis and treatment of myeloproliferative diseases |
| 04/30/1992 | WO1992007073A1 Osteogenic peptides |
| 04/30/1992 | WO1992007068A1 Amyloidin protease and uses thereof |
| 04/30/1992 | WO1992007001A1 Hepatitis c virus antibody |
| 04/30/1992 | WO1992007000A1 Pharmaceutical composition for the treatment or prevention of a malignant tumor |
| 04/30/1992 | WO1992006989A1 Varicella-zoster virus antigen |
| 04/30/1992 | WO1992006711A1 Blood coagulation protein antagonists and uses therefor |
| 04/30/1992 | WO1992006705A1 Heparin binding mitogen with homology to epidermal growth factor (egf) |
| 04/30/1992 | WO1992006697A1 Anti-inflammatory composition |
| 04/30/1992 | WO1992004448A3 Human mitochondrial nad(p)+-dependent malate enzyme |
| 04/30/1992 | WO1992004443A3 B cell deficient transgenic fbv/n mice |
| 04/30/1992 | WO1992002815A3 Quantitative analysis and monitoring of protein structure by subtractive chromatography |
| 04/30/1992 | CA2094372A1 Blood coagulation protein antagonists and uses therefor |
| 04/30/1992 | CA2094045A1 Heparin binding mitogen with egf homology |
| 04/30/1992 | CA2093919A1 Hepatitis c virus antibody |
| 04/29/1992 | EP0482185A1 Cell internalizable conjugates and complexes including intracellularly cleavable moieties |
| 04/29/1992 | EP0482176A1 Monoclonal antibodies specific for toxin b of clostridium difficile |
| 04/29/1992 | EP0482086A1 Antagonists of gm-csf derived from the carboxyl terminus |
| 04/29/1992 | EP0482018A1 Toxin uses |
| 04/29/1992 | CN1060680A 重组马立克氏病病毒 Recombinant Marek's Disease Virus |
| 04/28/1992 | US5109115 Monoclonal antibody specific for bombesin |
| 04/28/1992 | US5109113 Membrane anchor fusion polypeptides |
| 04/28/1992 | US5108900 For use in immunoassay to detect pesticides in foods and the environment |
| 04/28/1992 | US5108744 Vaccines for Haemophilus influenzae |
| 04/27/1992 | WO1992007944A1 Vaccinia vectors, vaccinia genes and expression products thereof |
| 04/27/1992 | WO1992007878A1 Neutralizing human monoclonal antibodies specific for the v3 loop and cd-4 binding site of hiv-1 gp120 |
| 04/27/1992 | CA2094821A1 Vaccinia vectors, vaccinia genes and expression products thereof |
| 04/27/1992 | CA2094713A1 Neutralizing human monoclonal antibodies specific for the v3 loop and cd-4 binding site of hiv-1 gp120 |
| 04/23/1992 | WO1992006709A1 Lipid a composition as immunogenic agents to prevent or treat gram-negative bacterial infections |
| 04/23/1992 | DE4033120A1 Genomic DNA fragment encoding antibody variable region prodn. - by attaching primers to hybridoma DNA then subjecting to polymerase chain reaction, for constructing genes encoding chimeric antibodies |
| 04/23/1992 | CA2094588A1 Lipid a composition as immunogenic agents to prevent or treat gram-negative bacterial infections |
| 04/22/1992 | EP0481970A2 Monoclonal antibodies against endotoxin of gram-negative bacteria |
| 04/22/1992 | EP0481791A2 Culture medium for CHO-cells and adapted CHO-cells |
| 04/22/1992 | EP0481790A2 Antibody production |
| 04/22/1992 | EP0481502A2 Process for the production of chimaeric antibodies |
| 04/22/1992 | EP0481089A1 Human monoclonal antibody against glycoprotein gp iii of varicella zoster virus |
| 04/22/1992 | EP0481070A1 Multimeric gelsolin fusion constructs |
| 04/22/1992 | EP0481000A1 Receptors for fibroblast growth factors |
| 04/22/1992 | EP0472599A4 Methods and systems for determining the presence of a pneumocystis carinii antigen in blood |
| 04/22/1992 | EP0245291B1 Monoclonal antibody for recovery of leukocytes in human peripheral blood and method of recovery employing said monoclonal antibody |
| 04/22/1992 | EP0222874B1 A single vial technique for radiolabeling protein |
| 04/22/1992 | CN1060499A Human zona pellucida protein zp3 |